NCT00048022View on ClinicalTrials.gov

Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent Asthma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 25, 2002

Primary Completion Date

February 2, 2004

Study Completion Date

February 2, 2004

Conditions
Asthma
Interventions
DRUG

Dual Integrin Antagonist

Trial Locations (60)

11570

Rockville Centre

11735

Farmingdale

14618

Rochester

19013

Upland

19115

Philadelphia

19140

Philadelphia

24210

Abingdon

26505

Morgantown

28801

Asheville

29425

Charleston

30309

Atlanta

32308

Tallahassee

33321

Tamarac

33609

Tampa

33613

Tampa

34233

Sarasota

44718

Canton

45231

Cincinnati

46208

Indianapolis

48197

Ypsilanti

52240

Iowa City

59804

Missoula

60611

Chicago

60637

Chicago

61761

Normal

66219

Lenexa

68114

Omaha

70006

Metairie

73120

Oklahoma City

75230

Dallas

75231

Dallas

77478

Sugar Land

78750

Austin

80027

Louisville

80206

Denver

80304

Boulder

84107

Murray

89104

Las Vegas

90025

Los Angeles

92103

San Diego

92120

San Diego

92647

Huntington Beach

92691

Mission Viejo

94598

Walnut Creek

95128

San Jose

97213

Portland

97401

Eugene

97504

Medford

98034

Kirkland

98105

Seattle

98225

Bellingham

98405

Tacoma

90095-1690

Los Angeles

02745

North Dartmouth

08731

Forked River

07666

Teaneck

02906

Providence

05403

South Burlington

53792-9988

Madison

00732

Ponce

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00048022 - Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent Asthma | Biotech Hunter | Biotech Hunter